NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
$69.24
arrow_upward
+1.30%(+0.89) 1D
Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMY...
Open
$69.00
High
$69.51
Low
$68.84
Mkt. cap
188.58B
Avg. vol.
23.27K
Volume
24.41K
52-wk high
$75.26
52-wk low
$49.90
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
Open
$69.00
High
$69.51
Low
$68.84
Mkt. cap
188.58B
Avg. vol.
23.27K
Volume
24.41K
52-wk high
$75.26
52-wk low
$49.90
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
www.marketscreener.com
·
18 hours ago
Transactions under Novonesis’ share buyback program
Profile
Novozymes A/S is a Danish biotechnology company. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has approximately 11,600 employees and activities in over 45 countries. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR